Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Times Interest Earned (2017 - 2022)

Sutro Biopharma (STRO) has disclosed Times Interest Earned for 6 consecutive years, with -$7.61 as the latest value for Q3 2022.

  • Quarterly Times Interest Earned rose 82.01% to -$7.61 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$56.98 through Jun 2023, down 19.22% year-over-year, with the annual reading at -$31.41 for FY2021, 80.2% down from the prior year.
  • Times Interest Earned hit -$7.61 in Q3 2022 for Sutro Biopharma, up from -$32.62 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $23.84 in Q2 2018 to a low of -$59.56 in Q1 2022.
  • Historically, Times Interest Earned has averaged -$17.14 across 5 years, with a median of -$12.3 in 2019.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 161.0% in 2020 and later plummeted 822.81% in 2021.
  • Year by year, Times Interest Earned stood at $5.05 in 2018, then tumbled by 458.55% to -$18.09 in 2019, then soared by 161.0% to $11.04 in 2020, then crashed by 618.72% to -$57.25 in 2021, then skyrocketed by 86.71% to -$7.61 in 2022.
  • Business Quant data shows Times Interest Earned for STRO at -$7.61 in Q3 2022, -$32.62 in Q2 2022, and -$59.56 in Q1 2022.